The Global Biopharmaceutical Contract Manufacturing Industry is poised for significant growth, driven by a projected Compound Annual Growth Rate (CAGR) of 8.8%. According to a recent market analysis, the market is expected to ascend from US$10.7 billion in 2024 to a staggering US$25.1 billion by 2034. This translates to a near doubling in market size …
Tag Archives: Global Biopharmaceutical Contract Manufacturing Industry
Global Biopharmaceutical Contract Manufacturing Industry Poised for 8.8% CAGR, Aims for US$ 25.1 Billion Market Triumph by 2034 | FMI Reports
The Global Biopharmaceutical Contract Manufacturing Industry is poised for remarkable expansion, anticipating a Compound Annual Growth Rate (CAGR) of 8.8% throughout the projected period. According to the latest insights, the market’s value is forecasted to surge from US$ 10.7 billion in 2024 to an impressive US$ 25.1 billion by the year 2034. This projection reflects …
Global Biopharmaceutical Contract Manufacturing Industry on Track for 10.5% CAGR, Envisions US$18.7 Billion Market by 2029 | According to FMI
The Global Biopharmaceutical Contract Manufacturing Industry, valued at an estimated US$9.3 billion in 2022, is poised for a remarkable surge with a projected Compound Annual Growth Rate (CAGR) of 10.5%. Forecasts indicate that by 2029, the industry is set to hit a staggering US$18.7 billion. This unprecedented growth underscores the accelerating trend among pharmaceutical companies …